跳至主要内容
临床试验/NL-OMON42780
NL-OMON42780已完成3 期

Pharmacokinetics of escalating doses of clonidine in ICU patients - Clonidine kinetics 1.1

Deventer Ziekenhuis0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * at least 18 years of age
  • * intubated
  • at the start of the study. Because of the high incidence of delirium on the ICU in all age categories, all age groups > 18 years will be included.

排除标准

  • * Severe neurotrauma,
  • * Severe dementia (living in a nursing home)
  • * Inability to speak Dutch or English, which is one of the causes of not being able to use the CAM-ICU.
  • * The use of clonidine during the 96 hours before the start of the study.
  • * Bradycardia (<50/min)
  • * Severe hypotension (MAP < 65 after volume resuscitation and vasopressors)
  • * Pregnancy and lactation (pregnancy test are routinely performed in premenopausal women on the ICU).
  • * Epilepsy
  • * Known clonidine intolerance
  • * Liver cirrhosis (Child Pugh class C)
  • * Recent and acute myocardial infarction
  • * Severe heart failure (LVEF < 30%)
  • * Second or third degree AV-block without a permanent pacemaker
  • * Expected transfer to another hospital
  • When renal failure (eGFR <30ml/min): maximum dose of clonidine will be 1200mcg

研究者

相似试验